Page 13 - ஹார்ட் ஸ்காட் ரோடினோ நம்பிக்கையற்ற மேம்பாடுகள் நாடகம் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

MorphoSys Commences Cash Tender Offer for All Outstanding Shares of Constellation Pharmaceuticals ACCESSWIRE 17 Jun 2021, 08:31 GMT+10 PLANEGG, GERMANY / ACCESSWIRE / June 16, 2021 / MorphoSys AG (FSE:MOR)(NASDAQ:MOR) ( MorphoSys ) today announced that it is commencing a cash tender offer to purchase all outstanding shares of Constellation Pharmaceuticals, Inc., (CNST) ( Constellation ) for $34.00 per share, net to the seller in cash, without interest, and subject to any applicable withholding of taxes. The tender offer is being made pursuant to the previously announced merger agreement, dated June 2, 2021 between MorphoSys and Constellation. The tender offer is scheduled to expire at one minute past 11:59 p.m. New York City Time, on July 14, 2021, unless extended or earlier terminated, in each case in accordance with the terms of the merger agreement. The tender offer is subject to various conditions including a minimum tender of at least a majority of outstanding Constellation

New yorkUnited statesRosen katzThomas biegiJulia neugebauerMyles cloustonJeanette bressiJanssen biotech incDrug administrationMorphosys development incMeagher flomConstellation pharmaceuticals incInnisfree ma incorporatedCenterview partnersJanssen research developmentMorphosys us inc